Pre-existing albuminuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy
- PMID: 21685547
- PMCID: PMC3119869
- DOI: 10.3851/IMP1766
Pre-existing albuminuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy
Abstract
Background: We previously reported an increased risk of all-cause and AIDS mortality among HIV-infected women with albuminuria (proteinuria or microalbuminuria) enrolled in the Women's Interagency HIV Study (WIHS) prior to the introduction of HAART.
Methods: The current analysis includes 1,073 WIHS participants who subsequently initiated HAART. Urinalysis for proteinuria and semi-quantitative testing for microalbuminuria from two consecutive study visits prior to HAART initiation were categorized as follows: confirmed proteinuria (both specimens positive for protein), confirmed microalbuminuria (both specimens positive with at least one microalbuminuria), unconfirmed albuminuria (one specimen positive for proteinuria or microalbuminuria), or negative (both specimens negative). Time from HAART initiation to death was modelled using proportional hazards analysis.
Results: Compared with the reference group of women with two negative specimens, the hazard ratio (HR) for all-cause mortality was significantly increased for women with confirmed microalbuminuria (HR 1.9, 95% CI 1.2-2.9). Confirmed microalbuminuria was also independently associated with AIDS death (HR 2.3, 95% CI 1.3-4.3), whereas women with confirmed proteinuria were at increased risk for non-AIDS death (HR 2.4, 95% CI 1.2-4.6).
Conclusions: In women initiating HAART, pre-existing microalbuminuria independently predicted increased AIDS mortality, whereas pre-existing proteinuria predicted increased risk of non-AIDS death. Urine testing may identify HIV-infected individuals at increased risk for mortality even after the initiation of HAART. Future studies should consider whether these widely available tests can identify individuals who would benefit from more aggressive management of HIV infection and comorbid conditions associated with mortality in this population.
Conflict of interest statement
Figures
Similar articles
-
Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infection.J Acquir Immune Defic Syndr. 2010 Sep;55(1):73-7. doi: 10.1097/QAI.0b013e3181cc1070. J Acquir Immune Defic Syndr. 2010. PMID: 20098331 Free PMC article.
-
Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008.Am J Epidemiol. 2013 Jan 15;177(2):116-25. doi: 10.1093/aje/kws321. Epub 2013 Jan 3. Am J Epidemiol. 2013. PMID: 23287403 Free PMC article.
-
The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy.Ann Intern Med. 2004 Feb 17;140(4):256-64. doi: 10.7326/0003-4819-140-4-200402170-00007. Ann Intern Med. 2004. PMID: 14970148
-
Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy.Clin Infect Dis. 2004 Oct 15;39(8):1199-206. doi: 10.1086/424013. Epub 2004 Sep 27. Clin Infect Dis. 2004. PMID: 15486845
-
Survival rate of AIDS disease and mortality in HIV-infected patients: a meta-analysis.Public Health. 2016 Oct;139:3-12. doi: 10.1016/j.puhe.2016.05.004. Epub 2016 Jun 24. Public Health. 2016. PMID: 27349729 Review.
Cited by
-
Use of urine biomarker-derived clusters to predict the risk of chronic kidney disease and all-cause mortality in HIV-infected women.Nephrol Dial Transplant. 2016 Sep;31(9):1478-85. doi: 10.1093/ndt/gfv426. Epub 2016 Jan 10. Nephrol Dial Transplant. 2016. PMID: 26754833 Free PMC article.
-
Urinary biomarkers of kidney injury are associated with all-cause mortality in the Women's Interagency HIV Study (WIHS).HIV Med. 2014 May;15(5):291-300. doi: 10.1111/hiv.12113. Epub 2013 Dec 3. HIV Med. 2014. PMID: 24313986 Free PMC article.
-
Kidney disease risk factors associate with urine biomarkers concentrations in HIV-positive persons; a cross-sectional study.BMC Nephrol. 2019 Jan 3;20(1):4. doi: 10.1186/s12882-018-1192-y. BMC Nephrol. 2019. PMID: 30606136 Free PMC article.
-
Association of urine α1-microglobulin with kidney function decline and mortality in HIV-infected women.Clin J Am Soc Nephrol. 2015 Jan 7;10(1):63-73. doi: 10.2215/CJN.03220314. Epub 2014 Nov 4. Clin J Am Soc Nephrol. 2015. PMID: 25370597 Free PMC article.
-
Microalbuminuria in HIV disease.Am J Nephrol. 2013;37(5):443-51. doi: 10.1159/000350384. Epub 2013 Apr 20. Am J Nephrol. 2013. PMID: 23615312 Free PMC article.
References
-
- Kimmel PL, Umana WO, Bosch JP. Abnormal urinary protein excretion in HIV-infected patients. Clin Nephrol. 1993;39:17–21. - PubMed
-
- Gerstein HC, Mann JF, Yi Q, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286:421–426. - PubMed
Publication types
MeSH terms
Grants and funding
- UO1-AI-34994/AI/NIAID NIH HHS/United States
- UO1-AI-34989/AI/NIAID NIH HHS/United States
- U01 AI031834/AI/NIAID NIH HHS/United States
- UO1-HK-32632/HK/PHITPO CDC HHS/United States
- K23 AI066943/AI/NIAID NIH HHS/United States
- UO1-AI-35004/AI/NIAID NIH HHS/United States
- UO1-AI-34993/AI/NIAID NIH HHS/United States
- U01 AI034994/AI/NIAID NIH HHS/United States
- K23 DK077568/DK/NIDDK NIH HHS/United States
- UO1-AI-42590/AI/NIAID NIH HHS/United States
- U01 AI034993/AI/NIAID NIH HHS/United States
- UO1-AI-31834/AI/NIAID NIH HHS/United States
- K23-DK-077568/DK/NIDDK NIH HHS/United States
- K23-AI-66943/AI/NIAID NIH HHS/United States
- U01 AI035004/AI/NIAID NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- U01 AI034989/AI/NIAID NIH HHS/United States
- U01 HD032632/HD/NICHD NIH HHS/United States
- U01 AI042590/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical